GFAP and Alzheimer disease: Studies comparing different GFAP measurement techniques have found a strong correlation between Nucleic Acid Linked Immuno-Sandwich Assay and SIMOA plasma GFAP levels, with SIMOA demonstrating higher predictive power for AD diagnosis [242].